CASP3 and cancer: Meanwhile, cells treated with SNS-032 and TRAIL together showed increased caspase-8 and caspase-3 cleavage (Fig. 5B), consistent with an apoptotic mechanism Our results are consistent with the study by Lemke et al., which reported that SNS-032 sensitizes cancer cells to TRAIL [34].